Overview of epirubicin-based adjuvant therapy in breast cancer.

Clinical breast cancer

Volumn 1 Suppl 1, Issue , 2000, Pages

  Untch, M ^a   von Koch, F ^a   Kahlert, S ^a   Konecny, G ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; EPIRUBICIN;

ADJUVANT CHEMOTHERAPY; BREAST TUMOR; CLINICAL TRIAL; GENETICS; HUMAN; PROTO ONCOGENE; REVIEW;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; EPIRUBICIN; GENES, ERBB-2; HUMANS;

MLCS; MLOWN;

EID: 20544455066     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/cbc.2000.s.008     Document Type: Review

References (15)